These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The renal effect of calcitonin in hypoparathyroid patients. Sorensen OH, Hindberg I, Friis T. Acta Med Scand; 1972; 191(1-2):103-6. PubMed ID: 5032426 [No Abstract] [Full Text] [Related]
7. Paradoxic hypercalcemia and hypophosphatemia associated with chronic renal failure in horses. Tennant B, Bettleheim P, Kaneko JJ. J Am Vet Med Assoc; 1982 Mar 15; 180(6):630-4. PubMed ID: 7068501 [Abstract] [Full Text] [Related]
9. Oral magnesium load test for the assessment of intestinal magnesium absorption. Application in control subjects, absorptive hypercalciuria, primary hyperparathyroidism, and hypoparathyroidism. Nicar MJ, Pak CY. Miner Electrolyte Metab; 1982 Jul 15; 8(1):44-51. PubMed ID: 6897741 [Abstract] [Full Text] [Related]
16. The effect of bendroflumethiazide on the intestinal absorption of calcium in normocalcaemic renal stone formers and in hyperparathyroidism. Jorgensen FS, Transbol I. Acta Med Scand; 1974 Jul 15; 195(1-2):33-6. PubMed ID: 4817089 [No Abstract] [Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov 15; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
19. [Iatrogenic hypercalcemia in chronic renal failure]. Snarska J, Sulima-Gillow A, Młotkowska E, Chocianowicz H. Pol Tyg Lek; 1980 Nov 17; 35(46):1761-4. PubMed ID: 7243638 [No Abstract] [Full Text] [Related]